Stay updated on MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial page.

Latest updates to the MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial page
- ChecktodayChange DetectedThe clinical trial record for the MRTX0902 Phase 1 study is available, with study design, eligibility criteria, locations, and outcomes. It states that the study is terminated and is no longer seeking participants.SummaryDifference57%

- Check7 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.2 to v3.8.0, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedA banner announces NIH updates about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check21 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2; the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check28 days agoChange DetectedThe site footer revision indicator changed from v3.7.0 to v3.7.1 while the page continued to display a 403 error.SummaryDifference0.2%

- Check49 days agoChange DetectedThe study page now shows a 403 Forbidden error, and the previous study content is replaced by a standard error page with site navigation/footer visible.SummaryDifference18%

Stay in the know with updates to MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MRTX0902 for KRAS Mutation Solid Tumors Clinical Trial page.